Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial
about
Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients with an acute cardiovascular eventAcute management of unstable angina and non-ST segment elevation myocardial infarctionβ-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literatureRisks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic ReviewSudden cardiac death in China: current status and future perspectivesAcute ischemic heart disease and interventional cardiology: a time for pauseDue caution using early beta-blockers for acute myocardial infarctionMicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotectionDuty hour reform in a shifting medical landscapeRole of risk stratification and genetics in sudden cardiac death.Acute coronary syndromes: diagnosis and management, part INonantithrombotic medical options in acute coronary syndromes: old agents and new lines on the horizon.Pre-hospital ECG for acute coronary syndrome in urban India: a cost-effectiveness analysis.The China Patient-Centered Evaluative Assessment of Cardiac Events (China PEACE) retrospective study of acute myocardial infarction: study design.Effect of beta-blockers on the risk of atrial fibrillation in patients with acute myocardial infarction.β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction.National assessment of early β-blocker therapy in patients with acute myocardial infarction in China, 2001-2011: The China Patient-centered Evaluative Assessment of Cardiac Events (PEACE)-Retrospective AMI Study.GNAS gene variants affect β-blocker-related survival after coronary artery bypass grafting.Growing epidemic of coronary heart disease in low- and middle-income countriesMyocardial infarction (ST-elevation).Current and emerging antiarrhythmic drug therapy for ventricular tachycardiabeta-Blocker use following myocardial infarction: low prevalence of evidence-based dosing.The relation between hypointense core, microvascular obstruction and intramyocardial haemorrhage in acute reperfused myocardial infarction assessed by cardiac magnetic resonance imagingIn-hospital arrhythmias in patients with acute myocardial infarction - the relation to the reperfusion strategy and their prognostic impact.Trends in the use of guideline-recommended medications and in-hospital mortality of patients with acute myocardial infarction in a Chinese population.Management and outcomes of acute ST-segment-elevation myocardial infarction at a tertiary-care hospital in Sri Lanka: an observational study.Strategies for the prevention and treatment of sudden cardiac death.Beta 2 antagonism in acute respiratory failurePatient satisfaction at America's lowest performing hospitals.Beta blocker use after acute myocardial infarction in the patient with normal systolic function: when is it "ok" to discontinue?Effect of Beta-Blocker Dose on Survival After Acute Myocardial Infarction.Demographics, Management Strategies, and Problems in ST-Elevation Myocardial Infarction from the Standpoint of Emergency Medicine Specialists: A Survey-Based Study from Seven Geographical Regions of Turkey.A Review of Current Diagnosis, Investigation, and Management of Acute Coronary Syndromes in Elderly Patients.Qingdao Port Cardiovascular Health Study: a prospective cohort study.Non ST segment elevation acute coronary syndromes: A simplified risk-orientated algorithm.Acute ST-elevation myocardial infarction.Gender and Age Differences in Short- and Long-Term Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.Early management of ST elevation myocardial infarction: a review of practice.Effect of early bisoprolol administration on ventricular arrhythmia and cardiac death in patients with non-ST elevation myocardial infarctionAdrenergic-pathway gene variants influence beta-blocker-related outcomes after acute coronary syndrome in a race-specific manner
P2860
Q24240551-A6B6C59C-48A7-428A-BC3C-CAE1D8D849ACQ26783157-C1A17290-FE05-4B69-AF5F-9B8D1CD7148DQ26861630-1038DDD5-83FD-453B-A566-5DFA1709DD00Q27026079-9DDE2335-616F-47ED-950B-017D82510971Q28077499-5E7416D8-18B8-4D92-9EF8-9B2880C6EFE6Q28200642-B6D579DA-4F28-4C63-A4C7-38DD23540EB3Q28218683-6F9A7CDD-F630-4BB1-A22D-2D1B28040A01Q28251007-5B1F1EBA-D4A9-43CD-88EE-652076516913Q28288657-0736B1B3-A4C7-4FDD-B456-7C1C81C568C2Q30240811-97291A79-6629-4680-B8CD-3285F6EB2D72Q30490718-C2989FB9-55A8-427C-B22C-7377C70F62C0Q30583012-3DF8064F-F79E-44D5-BD9C-7723F71057F1Q33540026-327D9BA7-E287-4190-94BF-E86234A17390Q33745054-34609B25-AFAF-4CF8-9FE0-D21B4E07DB67Q33754067-EB63EE5E-3A62-4DDA-A349-D32EF70E604BQ33758547-F97BFA7F-68F0-48AF-A0C9-C61C98C1E4DDQ33764581-E7A16BB1-A0E8-4816-B0F4-59FE34651B91Q33803705-C6F29778-6B9F-4AB7-93E0-48C4BCC03C93Q33828135-32334210-9144-4456-A111-388F41570441Q33866536-98129797-9CAD-4DCE-AB58-5D31E773FFF6Q33936131-D20B36D2-3BFF-4726-B77C-BD5AEDD75DB9Q34125706-84749E0C-BB1D-4BFC-9579-06455748B4B8Q34507513-0F2738FF-2901-4D81-892D-6F93069EB444Q34699693-8AC58D18-74BD-4E4A-B793-49DE9BB99F19Q35112939-9A465A85-B514-4BDE-B919-274248653BCDQ35180854-7104B27F-0DC2-4E49-B03B-28CDC38B3BBBQ35560103-96C4841E-25AE-4EBE-9CC6-1C619293F159Q35561393-1B1DFA85-98D9-435A-8CEA-4713787510C0Q35974348-77569619-12C3-4FA5-9094-9CAA4917120AQ36087931-056D6AFF-F55A-4F2D-B5D6-0445000BE536Q36094414-050F216E-8022-4C79-98BF-8ADA96675A38Q36168090-F2EB5889-8F22-4226-827D-B2F753378163Q36363183-F40FDED4-24E0-42A9-8C8B-3CAEBA9A9586Q36374072-D16E7167-F03C-44D9-9975-82D4CEDCFCD4Q36519924-3E341CEE-42F0-47C3-A192-26D558BC9002Q36714323-F09A232C-FFD6-4EEE-94E2-A5EAA3A2ACA0Q36721807-1605A16A-BBB5-4CD2-825E-7685C4238014Q36739783-7B54A9C9-CED0-4CAD-8A37-6DA36B8747EEQ36801124-1A4425D4-A110-42B0-BBF1-F3C4C43FE2ACQ36919549-7BB867EF-CCC3-461C-84CB-BDF34BF8F3A0
P2860
Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Early intravenous then oral me ...... mised placebo-controlled trial
@ast
Early intravenous then oral me ...... mised placebo-controlled trial
@en
Early intravenous then oral me ...... mised placebo-controlled trial
@nl
type
label
Early intravenous then oral me ...... mised placebo-controlled trial
@ast
Early intravenous then oral me ...... mised placebo-controlled trial
@en
Early intravenous then oral me ...... mised placebo-controlled trial
@nl
prefLabel
Early intravenous then oral me ...... mised placebo-controlled trial
@ast
Early intravenous then oral me ...... mised placebo-controlled trial
@en
Early intravenous then oral me ...... mised placebo-controlled trial
@nl
P2093
P3181
P1433
P1476
Early intravenous then oral me ...... mised placebo-controlled trial
@en
P2093
P304
P3181
P356
10.1016/S0140-6736(05)67661-1
P407
P577
2005-11-05T00:00:00Z